Guideline | Drug Name |
---|---|
Sylvant (siltuximab) | Sylvant (siltuximab) |
Symdeko (tezacaftor/ivacaftor) | Symdeko (tezacaftor/ivacaftor) |
Symlin (pramlintide acetate injection) | Symlin (pramlintide acetate) |
Synagis (palivizumab) | Synagis (palivizumab) |
Tabrecta (capmatinib) | Tabrecta (capmatinib) |
Tafinlar (dabrafenib) | Tafinlar (dabrafenib) |
Tagrisso (osimertinib) | Tagrisso (osimertinib) |
Taltz (ixekizumab) | Taltz (ixekizumab) |
Talvey (talquetamab-tgvs) | Talvey (talquetamab-tgvs) |
Talzenna (talazoparib) - PA, NF | Talzenna (talazoparib) |
Tarceva (erlotinib) | Tarceva (erlotinib) |
Targretin (bexarotene) | Targretin (bexarotene) capsules, Targretin (bexarotene) gel 1% |
Tarpeyo (budesonide) - PA, NF | Tarpeyo (budesonide) |
Tasigna (nilotinib) | Tasigna (nilotinib) |
Tavalisse (fostamatinib) | Tavalisse (fostamatinib) |
Tavneos (avacopan) - PA, NF | Tavneos (avacopan) |
Tazverik (tazemetostat) - PA, NF | Tazverik (tazemetostat) |
Tecelra (afamitresgene autoleucel) - PA, NF | Tecelra (afamitresgene autoleucel) |
Tecfidera (dimethyl fumarate) - PA, NF | Tecfidera (dimethyl fumarate) |
Temodar (temozolomide) | Temodar (temozolomide) |